ESC 365 - It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI - Rebuttal PRO. .(Via ZOOM)

Open Access

It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI - Rebuttal PRO. .(Via ZOOM)

Session: Great debate on STEMI: current controversies on antiplatelet management after the acute phase

Topic: Acute Coronary Syndromes: Post-Infarction Period

Speaker: Professor P. Vranckx (Hasselt, BE)

Event: Acute Cardiovascular Care 2018

Congress Presentation

Add to my library

About the speaker

Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)

32 presentations

5 followers

9 more presentations in this session

Risk scores are helpful for defining optimal DAPT duration - PRO.

Speaker: Professor S. De Servi (Sesto San Giovanni, IT)

Risk scores are helpful for defining optimal DAPT duration - CONTRA.

Speaker: Professor A. Budaj (Warsaw, PL)

Risk scores are helpful for defining optimal DAPT duration - Rebuttal PRO.

Speaker: Professor S. De Servi (Sesto San Giovanni, IT)

Risk scores are helpful for defining optimal DAPT duration - Rebuttal CONTRA.

Speaker: Professor A. Budaj (Warsaw, PL)

Risk scores are helpful for defining optimal DAPT duration: Chairpersons conclusion.

Access the full session

Great debate on STEMI: current controversies on antiplatelet management after the acute phase

Speakers: Professor P. Vranckx, Professor S. De Servi, Professor A. Budaj, Professor S. De Servi, Professor A. Budaj

About the event

Acute Cardiovascular Care 2018

3 March - 5 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources